Noom announced the Noom Band on Monday at the HLTH 2026 conference in Las Vegas, a wearable that will be bundled into its enterprise obesity care programs at no additional upfront cost to employer and health plan clients when it launches in early 2027. The device, powered by Sensor Bio's sensors, is designed to feed continuous data on sleep, activity, heart rate, heart rate variability and SpO2 directly into Noom's behavior-change programs, filling what CEO Geoff Cook called a major data gap in the company's metabolic health offerings.
Noom's Strategic Shift: Introducing the Noom Band
The launch marks the latest step in Noom's evolution from a consumer weight-loss app into a clinical metabolic health platform. The company now works with insurers and employers, offering programs for weight loss, diabetes and diabetes prevention, alongside access to weight-loss medications and psychology-based support, as MedCity News reported. Until now, that stack lacked one ingredient: a continuous stream of physiological signals from members' own bodies. The Noom Band is Noom's answer, built not to compete with fitness trackers on features but to close the loop between daily behavior and clinical outcomes.





